Andrew D. Sklawer serves as Executive at Brickell Biotech, Inc., where they oversee executive responsibilities. Since joining the company, Andrew D. Sklawer has executed 6 insider transactions totaling $12.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 2, 2023 involved selling 20,833 shares valued at $20.4K.
Andrew D. Sklawer currently holds 39,269 shares of Brickell Biotech, Inc. (BBI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew D. Sklawer has been a net buyer of BBI stock. They have purchased $12.3K and sold $0 worth of shares.
Andrew D. Sklawer's most recent insider trade was on Oct 2, 2023, when they sold 20,833 shares at $0.98 per share.
Get notified when new Form 4 filings are submitted
| 55,000 |
| $N/A |
| Discretionary |
| May 17, 2021 | BBI | $12.3K | Purchase | 15,375 | $0.80 | Discretionary |
| Mar 16, 2021 | BBI | $0 | Option Exercise | 20,000 | $N/A | Discretionary |
| Mar 16, 2021 | BBI | $8.0K | Payment | 7,000 | $1.14 | Discretionary |
| Jun 22, 2020 | BBI | $0 | Purchase | 13,044 | $N/A | Discretionary |